0170B |
Alcohol Panel, Blood |
0170FL |
Alcohol Panel, Fluid |
0170SP |
Alcohol Panel, Serum/Plasma |
0170TI |
Alcohol Panel, Tissue |
0170U |
Alcohol Panel, Urine |
0171B |
Alcohol Screen, Blood |
0171FL |
Alcohol Screen, Fluid |
0171SP |
Alcohol Screen, Serum/Plasma |
0171TI |
Alcohol Screen, Tissue |
0171U |
Alcohol Screen, Urine |
0175B |
Alcohol (DUID/DRE), Blood (Forensic) |
0175SP |
Alcohol (DUID/DRE), Serum/Plasma (Forensic) |
0175U |
Alcohol (DUID/DRE), Urine (Forensic) |
0568B |
Benzodiazepines Screen, Blood |
0568FL |
Benzodiazepines Screen, Fluid |
0568SP |
Benzodiazepines Screen, Serum/Plasma |
0568U |
Benzodiazepines Screen, Urine |
0770B |
Brompheniramine, Blood |
0770SP |
Brompheniramine, Serum/Plasma |
0770U |
Brompheniramine, Urine |
0985B |
Carbinoxamine, Blood |
1019B |
Carbrital Profile, Blood |
1019SP |
Carbrital Profile, Serum/Plasma |
1040B |
Cetirizine, Blood |
1040SP |
Cetirizine, Serum/Plasma |
1040U |
Cetirizine, Urine |
1190B |
Chlorpheniramine, Blood |
1190SP |
Chlorpheniramine, Serum/Plasma |
1190U |
Chlorpheniramine, Urine |
1425B |
Cyproheptadine, Blood |
1425SP |
Cyproheptadine, Serum/Plasma |
1425U |
Cyproheptadine, Urine |
1476B |
Delta-8 Cannabinoids Panel (DUID/DRE), Blood (Forensic) |
1479B |
Delta-8 and Delta-9 Cannabinoids Panel (DUID/DRE), Blood (Forensic) |
1760B |
Diphenhydramine, Blood |
1760FL |
Diphenhydramine, Fluid |
1760SP |
Diphenhydramine, Serum/Plasma |
1760TI |
Diphenhydramine, Tissue |
1760U |
Diphenhydramine, Urine |
1817B |
Doxylamine, Blood |
1817FL |
Doxylamine, Fluid |
1817SP |
Doxylamine, Serum/Plasma |
1817TI |
Doxylamine, Tissue |
1817U |
Doxylamine, Urine |
1858B |
Drugs of Abuse (10 Panel) and Alcohol Screen, Blood |
1858FL |
Drugs of Abuse (10 Panel) and Alcohol Screen, Fluid |
1858SP |
Drugs of Abuse (10 Panel) and Alcohol Screen, Serum/Plasma |
1858TI |
Drugs of Abuse (10 Panel) and Alcohol Screen, Tissue |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1861B |
Drugs of Abuse Screen (7 Panel), Blood |
1861U |
Drugs of Abuse Screen (6 Panel), Urine |
1864B |
Drugs of Abuse Screen (11 Panel), Blood |
1864FL |
Drugs of Abuse Screen (11 Panel), Fluid |
1864ME |
Drugs of Abuse Screen (10 Panel), Meconium |
1864SP |
Drugs of Abuse Screen (11 Panel), Serum/Plasma |
1864TI |
Drugs of Abuse Screen (11 Panel), Tissue |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874B |
Drug Screen (10 Panel), Blood |
1874U |
Drug Screen (9 Panel), Urine |
1876B |
Drug Screen - Expanded, Blood |
1876FL |
Drug Screen - Expanded, Fluid |
1876SP |
Drug Screen - Expanded, Serum/Plasma |
1876U |
Drug Screen - Expanded, Urine |
2041U |
Flunitrazepam and Metabolites, Urine |
2064SP |
Ethylmorphine, Serum/Plasma |
2068B |
Famotidine, Blood |
2276B |
Heroin Metabolites - Free (Unconjugated), Blood |
2276SP |
Heroin Metabolites - Free (Unconjugated), Serum/Plasma |
2276U |
Heroin Metabolites - Free (Unconjugated), Urine |
2365B |
Hydroxyzine and Metabolite, Blood |
2365FL |
Hydroxyzine and Metabolite, Fluid |
2365SP |
Hydroxyzine and Metabolite, Serum/Plasma |
2365U |
Hydroxyzine and Metabolite, Urine |
2517B |
Levocetirizine, Blood |
2517SP |
Levocetirizine, Serum/Plasma |
2525B |
Loratadine and Metabolite, Blood |
2525SP |
Loratadine and Metabolite, Serum/Plasma |
2525U |
Loratadine and Metabolite, Urine |
2760ME |
Methadone and Metabolite (Qualitative), Meconium |
3560B |
Pheniramine, Blood |
3740B |
Phenyltoloxamine, Blood |
3740SP |
Phenyltoloxamine, Serum/Plasma |
3970B |
Promethazine, Blood |
3970SP |
Promethazine, Serum/Plasma |
3970TI |
Promethazine, Tissue |
3970U |
Promethazine, Urine |
4640B |
Trichloroethanol - Free, Blood |
4640SP |
Trichloroethanol - Free, Serum/Plasma |
4720B |
Triprolidine, Blood |
4720SP |
Triprolidine, Serum/Plasma |
6904ME |
Drugs of Abuse Screen (7 Panel), Meconium |
6922H |
Benzodiazepines Screen, Hair |
6946H |
Drugs of Abuse Screen (9 Panel), Hair |
8030B |
Drug Facilitated Crime Panel, Blood (Forensic) |
8030SP |
Drug Facilitated Crime Panel, Serum/Plasma (Forensic) |
8030U |
Drug Facilitated Crime Panel, Urine (Forensic) |
8041B |
Postmortem, Basic w/Vitreous Alcohol Confirmation, Blood (Forensic) |
8050U |
Postmortem, Urine Screen Add-On (6-MAM Quantification only) (Forensic) Overview: Add-On Test |
8051B |
Postmortem, Basic, Blood (Forensic) |
8051FL |
Postmortem, Basic, Fluid (Forensic) |
8051SP |
Postmortem, Basic, Serum/Plasma (Forensic) |
8051TI |
Postmortem, Basic, Tissue (Forensic) |
8051U |
Postmortem, Basic, Urine (Forensic) |
8061B |
Postmortem, Basic w/o Alcohol, Blood (Forensic) |
8061TI |
Postmortem, Basic w/o Alcohol, Tissue (Forensic) |
8061U |
Postmortem, Basic w/o Alcohol, Urine (Forensic) |
8070U |
DUID/DRE Panel (w/Alcohol) (Qualitative), Urine (Forensic) |
8071U |
DUID/DRE Panel (Qualitative), Urine (Forensic) |
8083B |
Postmortem, Basic w/Vitreous Alcohol and 6-MAM Confirmation, Blood (Forensic) |
8098B |
Drug Screen (GC/MS), Blood |
8098SP |
Drug Screen (GC/MS), Serum/Plasma |
8098U |
Drug Screen (GC/MS), Urine |
8150B |
DUID/DRE Panel, Blood (Forensic) |
8151B |
DUID/DRE Panel (w/Alcohol), Blood (Forensic) |
8158B |
DUID/DRE Expanded Drug Screen (w/Alcohol), Blood (Forensic) |
8159B |
DUID/DRE Expanded Drug Screen, Blood (Forensic) |
8170U |
DUID/DRE Panel (w/Alcohol), Urine (Forensic) |
8171U |
DUID/DRE Panel, Urine (Forensic) |
8665B |
6-Monoacetylmorphine - Free (Unconjugated), Blood |
8665FL |
6-Monoacetylmorphine - Free (Unconjugated), Fluid |
8665SP |
6-Monoacetylmorphine - Free (Unconjugated), Serum/Plasma |
8665U |
6-Monoacetylmorphine - Free (Unconjugated), Urine |
8670ME |
Opiates - Total (Conjugated/Unconjugated) (Qualitative), Meconium |
8891OF |
Benzodiazepines Panel (Qualitative), Oral Fluid (Saliva) |
8894OF |
Methadone and Metabolite (Qualitative), Oral Fluid (Saliva) |
8897OF |
Drugs of Abuse (7 Panel) (Qualitative), Oral Fluid (Saliva) |
8898OF |
Drugs of Abuse (6 Panel) (Qualitative), Oral Fluid (Saliva) |
9118B |
Brompheniramine Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9163B |
Doxylamine Screen, Blood |
9163SP |
Doxylamine Screen, Serum/Plasma |
9326B |
Gamma-Hydroxybutyric Acid Screen, Blood |
9326FL |
Gamma-Hydroxybutyric Acid Screen, Fluid |
9326SP |
Gamma-Hydroxybutyric Acid Screen, Serum/Plasma |
9326U |
Gamma-Hydroxybutyric Acid Screen, Urine |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9329SP |
Benzodiazepines Panel, Serum/Plasma |
9329TI |
Benzodiazepines Panel, Tissue |
9329U |
Benzodiazepines Panel, Urine |
9341B |
Flunitrazepam and Metabolites Screen, Blood |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9341U |
Flunitrazepam and Metabolites Screen, Urine |
9343B |
Heroin Screen, Blood |
9343SP |
Heroin Screen, Serum/Plasma |
9343U |
Heroin Screen, Urine |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |